Huda Zoghbi is a Howard Hughes Medical Institute investigator and professor of molecular and human genetics at Baylor College of Medicine in Houston, Texas. She is also director of the Jan and Dan Duncan Neurological Research Institute. Zoghbi explores the biology of genetic disorders such as Rett syndrome, and the genes essential for normal neurodevelopment.
Huda Zoghbi
Professor
Baylor College of Medicine
From this contributor
Remembering Steve Warren (1953-2021): A giant in the field of genetics
Steve Warren co-discovered the genetic mechanism that underpins fragile X syndrome and was a generous, inspiring mentor to many.
Remembering Steve Warren (1953-2021): A giant in the field of genetics
Questions for Huda Zoghbi: Studying Rett in the rodent brain
Removing the Rett syndrome gene, MeCP2, from distinct cells and brain regions reveals hidden features of the condition.
Questions for Huda Zoghbi: Studying Rett in the rodent brain
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.